Pete Robinson

Vice President, Medical and Scientific Management, Head, Cell and Gene Therapy Consortium • Syneos Health

Peter joined Syneos Health in May 2018 taking on the CGT consortium lead role as well as managing some corporate alliances. His Current role is to coordinate and integrate Syneos Healths CGT experience across all functions, therapeutic areas and business lines from pre-clinical to commercial. He has 20+ years experience in clinical research and 15 years working in cell and gene therapy, including acting as the project manager/ program oversight on the first global phase III stem cell trials

Peter has built partnerships with multiple CGT: developers, strategic providers, and companies of varying sizes and development stages, and is Familiar with all aspects of clinical trials:

  • Starting as a CRA and moving to Project Management and Alliance Management as his career progressed.   
  • Worked in Oncology for several years and then built and managed partnerships with key customers. 

Also Speaking

Jennifer Fenwick

Senior Manager, Personalized Supply Chain • World Courier

Marlin Frechette

Chief Quality & Compliance Officer • Fujifilm Irvine Scientific

Gregory Fiore

Founder and Chief Executive Officer • Exacis Biotherapeutics

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.